These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2720018)

  • 1. The significance of HPA axis disturbance in panic disorder.
    Coryell W; Noyes R; Schlechte J
    Biol Psychiatry; 1989 Apr; 25(8):989-1002. PubMed ID: 2720018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test in patients with panic attacks.
    Bridges M; Yeragani VK; Rainey JM; Pohl R
    Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467
    [No Abstract]   [Full Text] [Related]  

  • 3. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
    Coryell W; Noyes R; Clancy J; Crowe R; Chaudhry D
    Psychiatry Res; 1985 Aug; 15(4):301-11. PubMed ID: 2866558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial dexamethasone suppression tests in simultaneous panic and depressive disorders.
    Grunhaus L; Flegel P; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Mar; 22(3):332-8. PubMed ID: 3814682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.
    Stein MB; Uhde TW
    Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPA axis disturbance in obsessive-compulsive disorder.
    Coryell WH; Black DW; Kelly MW; Noyes R
    Psychiatry Res; 1989 Dec; 30(3):243-51. PubMed ID: 2694203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities in hypothalamic-pituitary-adrenal axis activity between patients with panic disorder and those experiencing external stress.
    Kathol RG; Noyes R; Lopez A
    Psychiatr Clin North Am; 1988 Jun; 11(2):335-48. PubMed ID: 3047703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks.
    Grunhaus L; Tiongco D; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Apr; 22(4):517-21. PubMed ID: 3567265
    [No Abstract]   [Full Text] [Related]  

  • 14. Basal adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients.
    Kopp MS; Arató M; Magyar I; Buza K
    Int J Psychophysiol; 1989 Mar; 7(1):77-83. PubMed ID: 2925467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients.
    Westberg P; Modigh K; Lisjö P; Eriksson E
    Biol Psychiatry; 1991 Aug; 30(3):247-56. PubMed ID: 1912116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders.
    Carson SW; Halbreich U; Yeh CM; Goldstein S
    Biol Psychiatry; 1988 May; 24(1):56-62. PubMed ID: 3370278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adrenocortical unresponsiveness in lactate-induced panic.
    Levin AP; Doran AR; Liebowitz MR; Fyer AJ; Gorman JM; Klein DF; Paul SM
    Psychiatry Res; 1987 May; 21(1):23-32. PubMed ID: 3037579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.